November 2008
Indivumed receives research contract from FDA for drug safety assessment in cancer
The Food and Drug Administration of the US (FDA) will explore Indivumed’s high-quality tissue biobank and research capabilities including a special drug profiling platform.
10th of November 2008, Hamburg, Germany—Growth factor receptors serve as potential candidates for new and more specific anti-cancer drugs if differentially expressed between cancer and normal tissue. On the other side, [...]
July 2008
Georgetown University Medical Research Center collaborates with Indivumed to develop cancer research database
Agreement is first step towards collecting—and analyzing—data designed to provide better, more personalized cancer treatment.
31st of July 2008, Washington, DC / Hamburg, Germany—The field of personalized cancer research and treatment grows with each day. And a new partnership with Washington’s largest biomedical research organization and an international research and biobanking company is contributing [...]
